Moody Aldrich Partners’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,438
Closed -$1.9M 173
2022
Q4
$1.9M Sell
11,438
-11,884
-51% -$1.86M 0.39% 87
2022
Q3
$3.28M Sell
23,322
-17,102
-42% -$3.12M 0.68% 64
2022
Q2
$8.24M Sell
40,424
-1,887
-4% -$413K 1.62% 13
2022
Q1
$10.8M Buy
42,311
+4,456
+12% +$1.21M 1.52% 20
2021
Q4
$12.4M Sell
37,855
-6,977
-16% -$2.19M 1.73% 8
2021
Q3
$13.6M Buy
44,832
+6,331
+16% +$1.8M 1.72% 8
2021
Q2
$10.4M Sell
38,501
-505
-1% -$128K 1.47% 14
2021
Q1
$9.5M Buy
39,006
+541
+1% +$149K 1.37% 19
2020
Q4
$11M Sell
38,465
-7,551
-16% -$2.08M 1.78% 4
2020
Q3
$11.7M Buy
46,016
+1,047
+2% +$249K 2.45% 2
2020
Q2
$9.75M Buy
44,969
+6,346
+16% +$1.46M 2.07% 3
2020
Q1
$8.73M Buy
38,623
+9,535
+33% +$2.35M 2.64% 1
2019
Q4
$7.25M Buy
+29,088
New +$6.81M 1.49% 14

Other funds holding MLAB

Moody Aldrich Partners's MLAB Position: Q1 2023 in Review

Moody Aldrich Partners sold out of Mesa Laboratories (MLAB) in Q1 2023, closing a stake of 11,438 shares — an estimated $1.9M sold.

Moody Aldrich Partners first reported a position in MLAB in Q4 2019 and held it in 13 quarters. The position peaked at $13.6M in Q3 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q1 2023.

  • Moody Aldrich Partners reported no remaining Mesa Laboratories position as of Q1 2023 after selling out during the quarter.
  • Moody Aldrich Partners sold 11,438 Mesa Laboratories shares in Q1 2023, an estimated $1.9M.
  • Moody Aldrich Partners first reported a position in Mesa Laboratories in Q4 2019 and held it in 13 quarters.
  • Moody Aldrich Partners's Mesa Laboratories position peaked at $13.6M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2023.

Based on Moody Aldrich Partners's 13F filing for Q1 2023, filed 27 Apr 2023.